OrbiMed Announces ISS Recommendation 3SBio Shareholders Vote AGAINST Management Buyout Proposal

OrbiMed Advisors LLC (“OrbiMed”) today announced that Institutional Shareholder Services (“ISS”), a leading provider of proxy research and corporate governance services to institutional shareholders, has recommended that shareholders of 3SBio (NASDAQ: SSRX ) vote AGAINST the company's $15.40 per ADS going-private acquisition by a consortium of buyers that includes the company's Chairman and CEO